tradingkey.logo

Zoetis Inc

ZTS

149.290USD

+0.270+0.18%
取引時間 ET15分遅れの株価
66.28B時価総額
26.32直近12ヶ月PER

Zoetis Inc

149.290

+0.270+0.18%
詳細情報 Zoetis Inc 企業名
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
企業情報
企業コードZTS
会社名Zoetis Inc
上場日Feb 01, 2013
最高経営責任者「CEO」Ms. Kristin C. Peck
従業員数13800
証券種類Ordinary Share
決算期末Feb 01
本社所在地10 Sylvan Way
都市PARSIPPANY
証券取引所NYSE Consolidated
United States of America
郵便番号07054
電話番号19738227000
ウェブサイトhttps://www.zoetis.com/
企業コードZTS
上場日Feb 01, 2013
最高経営責任者「CEO」Ms. Kristin C. Peck
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Mr. Robert J. Polzer, Ph.D.
Mr. Robert J. Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
2.82K
+51.75%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Parasiticides
562.00M
25.32%
Vaccines
447.00M
20.14%
Dermatology
390.00M
17.57%
Anti-infectives
249.00M
11.22%
Pain and sedation
210.00M
9.46%
Other
362.00M
16.31%
地域別USD
会社名
収益
比率
United States
1.18B
53.29%
Other emerging markets
248.00M
11.17%
Other Developed
133.00M
5.99%
Brazil
88.00M
3.96%
United Kingdom
77.00M
3.47%
Other
491.00M
22.12%
事業別
地域別
事業別USD
会社名
収益
比率
Parasiticides
562.00M
25.32%
Vaccines
447.00M
20.14%
Dermatology
390.00M
17.57%
Anti-infectives
249.00M
11.22%
Pain and sedation
210.00M
9.46%
Other
362.00M
16.31%
株主
更新時刻: Fri, Aug 8
更新時刻: Fri, Aug 8
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.22%
State Street Global Advisors (US)
4.47%
State Farm Insurance Companies
3.81%
Geode Capital Management, L.L.C.
2.50%
Other
74.59%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.22%
State Street Global Advisors (US)
4.47%
State Farm Insurance Companies
3.81%
Geode Capital Management, L.L.C.
2.50%
Other
74.59%
種類
株主統計
比率
Investment Advisor
49.03%
Investment Advisor/Hedge Fund
32.26%
Research Firm
4.82%
Insurance Company
3.92%
Bank and Trust
2.66%
Pension Fund
2.51%
Sovereign Wealth Fund
1.21%
Hedge Fund
1.21%
Family Office
0.14%
Other
2.25%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
2023Q1
2913
436.42M
94.33%
-5.14M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
41.36M
9.29%
+189.52K
+0.46%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
23.15M
5.2%
+208.71K
+0.91%
Mar 31, 2025
State Street Global Advisors (US)
19.80M
4.45%
-46.05K
-0.23%
Mar 31, 2025
State Farm Insurance Companies
16.88M
3.79%
-120.91K
-0.71%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.99M
2.47%
+368.11K
+3.47%
Mar 31, 2025
AllianceBernstein L.P.
10.86M
2.44%
-952.97K
-8.07%
Mar 31, 2025
Polen Capital Management, LLC
8.80M
1.98%
+1.31M
+17.55%
Mar 31, 2025
Wellington Management Company, LLP
6.07M
1.36%
-893.17K
-12.84%
Mar 31, 2025
Wells Fargo Advisors
6.01M
1.35%
+338.64K
+5.97%
Mar 31, 2025
BlackRock Asset Management Ireland Limited
5.36M
1.2%
+511.23K
+10.54%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Wed, Aug 6
更新時刻: Wed, Aug 6
銘柄名
比率
ProShares Pet Care ETF
9.46%
VanEck Agribusiness ETF
7.54%
iShares U.S. Pharmaceuticals ETF
3.94%
Honeytree US Equity ETF
3.6%
First Trust NASDAQ Pharmaceuticals ETF
3.55%
Jensen Quality Growth ETF
3.44%
Polen Capital Global Growth ETF
3.32%
SPDR S&P Pharmaceuticals ETF
3.31%
VanEck Pharmaceutical ETF
3.14%
Siren DIVCON Dividend Defender ETF
2.17%
詳細を見る
ProShares Pet Care ETF
比率9.46%
VanEck Agribusiness ETF
比率7.54%
iShares U.S. Pharmaceuticals ETF
比率3.94%
Honeytree US Equity ETF
比率3.6%
First Trust NASDAQ Pharmaceuticals ETF
比率3.55%
Jensen Quality Growth ETF
比率3.44%
Polen Capital Global Growth ETF
比率3.32%
SPDR S&P Pharmaceuticals ETF
比率3.31%
VanEck Pharmaceutical ETF
比率3.14%
Siren DIVCON Dividend Defender ETF
比率2.17%
配当金
過去5年間の配当金総支払額は 2.94B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI